跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 68,555 条关于
“IGF-1 receptor”
全部
68,555
临床试验
41,443
药物
8,522
机构
1,418
资讯
17,172
去年
Acelyrin Assembles Scientific and Patient Advisory Board for Lonigutamab's Phase 3 TED Trial
2年前
Acelyrin's Izokibep Shows Positive Phase 3 Data in Hidradenitis Suppurativa; Company Prioritizes Lonigutamab
去年
Acelyrin's Lonigutamab Shows Promise in Phase 2 Data for Thyroid Eye Disease
3个月前
Regeneron Unveils Pivotal Phase 3 Garetosmab Data in FOP as FDA Priority Review Underway, Alongside Metabolic and Ophthalmology Pipeline Advances
2年前
Acelyrin's Lonigutamab Shows Promise in Thyroid Eye Disease Phase 1/2 Trial
2年前
Acelyrin's Lonigutamab Shows Promise in Thyroid Eye Disease with Subcutaneous Delivery
去年
Graves' Disease and Graft-versus-Host Disease: Pipeline Therapeutics Update
去年
Percheron Therapeutics Discontinues Avicursen Trial for Duchenne Muscular Dystrophy After Phase 2 Failure
去年
Minghui Pharma's MHB018A Shows Promise in Thyroid Eye Disease Trial
去年
China Approves SYCUME®: First IGF-1R Antibody for Thyroid Eye Disease in 70 Years
第 1 页,共 1718 页
上一页
下一页